nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—atherosclerosis—metabolic syndrome X	0.532	0.649	CtDrD
Ezetimibe—coronary artery disease—metabolic syndrome X	0.287	0.351	CtDrD
Ezetimibe—ABCG5—liver—metabolic syndrome X	0.00249	0.101	CbGeAlD
Ezetimibe—NPC1L1—liver—metabolic syndrome X	0.00234	0.0953	CbGeAlD
Ezetimibe—ABCG8—liver—metabolic syndrome X	0.00222	0.0903	CbGeAlD
Ezetimibe—SOAT1—cardiovascular system—metabolic syndrome X	0.00129	0.0528	CbGeAlD
Ezetimibe—ANPEP—cardiovascular system—metabolic syndrome X	0.00124	0.0505	CbGeAlD
Ezetimibe—ANPEP—kidney—metabolic syndrome X	0.00121	0.0494	CbGeAlD
Ezetimibe—SOAT1—adipose tissue—metabolic syndrome X	0.00114	0.0465	CbGeAlD
Ezetimibe—ANPEP—adipose tissue—metabolic syndrome X	0.00109	0.0445	CbGeAlD
Ezetimibe—UGT1A3—liver—metabolic syndrome X	0.00099	0.0404	CbGeAlD
Ezetimibe—UGT2B15—liver—metabolic syndrome X	0.000931	0.0379	CbGeAlD
Ezetimibe—UGT2B7—kidney—metabolic syndrome X	0.000899	0.0367	CbGeAlD
Ezetimibe—SOAT1—liver—metabolic syndrome X	0.0008	0.0326	CbGeAlD
Ezetimibe—ANPEP—liver—metabolic syndrome X	0.000766	0.0312	CbGeAlD
Ezetimibe—UGT1A1—kidney—metabolic syndrome X	0.000765	0.0312	CbGeAlD
Ezetimibe—Pain in extremity—Metformin—metabolic syndrome X	0.000651	0.0321	CcSEcCtD
Ezetimibe—SLCO1B1—kidney—metabolic syndrome X	0.000636	0.0259	CbGeAlD
Ezetimibe—ABCC3—kidney—metabolic syndrome X	0.000604	0.0246	CbGeAlD
Ezetimibe—Liver function test abnormal—Metformin—metabolic syndrome X	0.000601	0.0296	CcSEcCtD
Ezetimibe—Breast disorder—Metformin—metabolic syndrome X	0.000588	0.029	CcSEcCtD
Ezetimibe—Cramp muscle—Metformin—metabolic syndrome X	0.000586	0.0289	CcSEcCtD
Ezetimibe—Nasopharyngitis—Metformin—metabolic syndrome X	0.000582	0.0287	CcSEcCtD
Ezetimibe—UGT2B7—liver—metabolic syndrome X	0.000568	0.0232	CbGeAlD
Ezetimibe—Influenza—Metformin—metabolic syndrome X	0.000562	0.0277	CcSEcCtD
Ezetimibe—Pancreatitis—Metformin—metabolic syndrome X	0.000551	0.0272	CcSEcCtD
Ezetimibe—ABCC3—adipose tissue—metabolic syndrome X	0.000544	0.0222	CbGeAlD
Ezetimibe—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000523	0.0258	CcSEcCtD
Ezetimibe—Infestation—Metformin—metabolic syndrome X	0.000501	0.0247	CcSEcCtD
Ezetimibe—Infestation NOS—Metformin—metabolic syndrome X	0.000501	0.0247	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000492	0.0242	CcSEcCtD
Ezetimibe—UGT1A1—liver—metabolic syndrome X	0.000483	0.0197	CbGeAlD
Ezetimibe—ABCC2—kidney—metabolic syndrome X	0.000482	0.0197	CbGeAlD
Ezetimibe—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000474	0.0234	CcSEcCtD
Ezetimibe—Hepatitis—Metformin—metabolic syndrome X	0.00045	0.0222	CcSEcCtD
Ezetimibe—Oedema peripheral—Metformin—metabolic syndrome X	0.000443	0.0219	CcSEcCtD
Ezetimibe—Connective tissue disorder—Metformin—metabolic syndrome X	0.000442	0.0218	CcSEcCtD
Ezetimibe—Flushing—Metformin—metabolic syndrome X	0.000418	0.0206	CcSEcCtD
Ezetimibe—Angiopathy—Metformin—metabolic syndrome X	0.000408	0.0201	CcSEcCtD
Ezetimibe—Immune system disorder—Metformin—metabolic syndrome X	0.000407	0.02	CcSEcCtD
Ezetimibe—Mediastinal disorder—Metformin—metabolic syndrome X	0.000406	0.02	CcSEcCtD
Ezetimibe—SLCO1B1—liver—metabolic syndrome X	0.000402	0.0164	CbGeAlD
Ezetimibe—ABCB1—blood vessel—metabolic syndrome X	0.000397	0.0162	CbGeAlD
Ezetimibe—Erythema—Metformin—metabolic syndrome X	0.000392	0.0193	CcSEcCtD
Ezetimibe—Malnutrition—Metformin—metabolic syndrome X	0.000392	0.0193	CcSEcCtD
Ezetimibe—Flatulence—Metformin—metabolic syndrome X	0.000386	0.019	CcSEcCtD
Ezetimibe—ABCC3—liver—metabolic syndrome X	0.000382	0.0156	CbGeAlD
Ezetimibe—Muscle spasms—Metformin—metabolic syndrome X	0.000377	0.0186	CcSEcCtD
Ezetimibe—Ill-defined disorder—Metformin—metabolic syndrome X	0.000364	0.0179	CcSEcCtD
Ezetimibe—Malaise—Metformin—metabolic syndrome X	0.000353	0.0174	CcSEcCtD
Ezetimibe—Palpitations—Metformin—metabolic syndrome X	0.000346	0.0171	CcSEcCtD
Ezetimibe—Hypertension—Metformin—metabolic syndrome X	0.000338	0.0167	CcSEcCtD
Ezetimibe—Chest pain—Metformin—metabolic syndrome X	0.000334	0.0164	CcSEcCtD
Ezetimibe—Myalgia—Metformin—metabolic syndrome X	0.000334	0.0164	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000331	0.0163	CcSEcCtD
Ezetimibe—Discomfort—Metformin—metabolic syndrome X	0.00033	0.0163	CcSEcCtD
Ezetimibe—Infection—Metformin—metabolic syndrome X	0.000318	0.0157	CcSEcCtD
Ezetimibe—ABCG2—adipose tissue—metabolic syndrome X	0.000317	0.0129	CbGeAlD
Ezetimibe—Nervous system disorder—Metformin—metabolic syndrome X	0.000314	0.0155	CcSEcCtD
Ezetimibe—Thrombocytopenia—Metformin—metabolic syndrome X	0.000313	0.0154	CcSEcCtD
Ezetimibe—Skin disorder—Metformin—metabolic syndrome X	0.000311	0.0153	CcSEcCtD
Ezetimibe—ABCC2—liver—metabolic syndrome X	0.000305	0.0124	CbGeAlD
Ezetimibe—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000291	0.0144	CcSEcCtD
Ezetimibe—Paraesthesia—Metformin—metabolic syndrome X	0.000287	0.0142	CcSEcCtD
Ezetimibe—Dyspnoea—Metformin—metabolic syndrome X	0.000285	0.0141	CcSEcCtD
Ezetimibe—Dyspepsia—Metformin—metabolic syndrome X	0.000282	0.0139	CcSEcCtD
Ezetimibe—Decreased appetite—Metformin—metabolic syndrome X	0.000278	0.0137	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000276	0.0136	CcSEcCtD
Ezetimibe—Fatigue—Metformin—metabolic syndrome X	0.000276	0.0136	CcSEcCtD
Ezetimibe—Constipation—Metformin—metabolic syndrome X	0.000273	0.0135	CcSEcCtD
Ezetimibe—Feeling abnormal—Metformin—metabolic syndrome X	0.000264	0.013	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000262	0.0129	CcSEcCtD
Ezetimibe—Urticaria—Metformin—metabolic syndrome X	0.000254	0.0125	CcSEcCtD
Ezetimibe—Abdominal pain—Metformin—metabolic syndrome X	0.000253	0.0125	CcSEcCtD
Ezetimibe—CYP3A4—kidney—metabolic syndrome X	0.000245	0.00999	CbGeAlD
Ezetimibe—Asthenia—Metformin—metabolic syndrome X	0.000229	0.0113	CcSEcCtD
Ezetimibe—Pruritus—Metformin—metabolic syndrome X	0.000226	0.0112	CcSEcCtD
Ezetimibe—ABCG2—liver—metabolic syndrome X	0.000222	0.00907	CbGeAlD
Ezetimibe—Diarrhoea—Metformin—metabolic syndrome X	0.000219	0.0108	CcSEcCtD
Ezetimibe—Dizziness—Metformin—metabolic syndrome X	0.000211	0.0104	CcSEcCtD
Ezetimibe—Vomiting—Metformin—metabolic syndrome X	0.000203	0.01	CcSEcCtD
Ezetimibe—Rash—Metformin—metabolic syndrome X	0.000202	0.00994	CcSEcCtD
Ezetimibe—Dermatitis—Metformin—metabolic syndrome X	0.000201	0.00993	CcSEcCtD
Ezetimibe—Headache—Metformin—metabolic syndrome X	0.0002	0.00988	CcSEcCtD
Ezetimibe—Nausea—Metformin—metabolic syndrome X	0.00019	0.00937	CcSEcCtD
Ezetimibe—ABCB1—cardiovascular system—metabolic syndrome X	0.000177	0.00723	CbGeAlD
Ezetimibe—ABCB1—kidney—metabolic syndrome X	0.000173	0.00707	CbGeAlD
Ezetimibe—ABCB1—adipose tissue—metabolic syndrome X	0.000156	0.00637	CbGeAlD
Ezetimibe—CYP3A4—liver—metabolic syndrome X	0.000155	0.00632	CbGeAlD
Ezetimibe—ABCB1—liver—metabolic syndrome X	0.00011	0.00447	CbGeAlD
Ezetimibe—ABCG2—Metabolism—GCKR—metabolic syndrome X	8.86e-06	6.53e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LPA—metabolic syndrome X	8.86e-06	6.53e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	8.74e-06	6.45e-05	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.73e-06	6.44e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.73e-06	6.44e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	8.73e-06	6.44e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	8.64e-06	6.38e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	8.63e-06	6.37e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—NOS3—metabolic syndrome X	8.58e-06	6.34e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLA2G6—metabolic syndrome X	8.58e-06	6.33e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TRIB3—metabolic syndrome X	8.52e-06	6.29e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOA5—metabolic syndrome X	8.49e-06	6.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	8.43e-06	6.22e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NAMPT—metabolic syndrome X	8.34e-06	6.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FMO3—metabolic syndrome X	8.34e-06	6.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LIPC—metabolic syndrome X	8.29e-06	6.12e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GCK—metabolic syndrome X	8.29e-06	6.12e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOC3—metabolic syndrome X	8.24e-06	6.08e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	8.2e-06	6.05e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	8.12e-06	5.99e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	8.1e-06	5.97e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.03e-06	5.93e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CETP—metabolic syndrome X	8e-06	5.9e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCA1—metabolic syndrome X	7.93e-06	5.86e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCA1—metabolic syndrome X	7.93e-06	5.86e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC2A4—metabolic syndrome X	7.93e-06	5.86e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC2A4—metabolic syndrome X	7.93e-06	5.86e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TRIB3—metabolic syndrome X	7.89e-06	5.82e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—metabolic syndrome X	7.85e-06	5.79e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	7.83e-06	5.78e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GGT1—metabolic syndrome X	7.68e-06	5.67e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GOT1—metabolic syndrome X	7.68e-06	5.67e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GGT1—metabolic syndrome X	7.68e-06	5.67e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GOT1—metabolic syndrome X	7.68e-06	5.67e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOB—metabolic syndrome X	7.67e-06	5.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SCARB1—metabolic syndrome X	7.66e-06	5.65e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NAMPT—metabolic syndrome X	7.65e-06	5.64e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.6e-06	5.61e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LIPC—metabolic syndrome X	7.6e-06	5.61e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GCK—metabolic syndrome X	7.6e-06	5.61e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	7.59e-06	5.6e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOC3—metabolic syndrome X	7.55e-06	5.57e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PLA2G4A—metabolic syndrome X	7.46e-06	5.51e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SREBF1—metabolic syndrome X	7.44e-06	5.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	7.43e-06	5.48e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EPHX2—metabolic syndrome X	7.43e-06	5.48e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CETP—metabolic syndrome X	7.33e-06	5.41e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—LPL—metabolic syndrome X	7.32e-06	5.4e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GOT2—metabolic syndrome X	7.23e-06	5.34e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMGCR—metabolic syndrome X	7.23e-06	5.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	7.17e-06	5.29e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NAMPT—metabolic syndrome X	7.08e-06	5.22e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LIPC—metabolic syndrome X	7.03e-06	5.19e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GCK—metabolic syndrome X	7.03e-06	5.19e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SCARB1—metabolic syndrome X	7.02e-06	5.18e-05	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—metabolic syndrome X	7.01e-06	5.17e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOC3—metabolic syndrome X	6.99e-06	5.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—G6PC2—metabolic syndrome X	6.99e-06	5.16e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CD36—metabolic syndrome X	6.96e-06	5.13e-05	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	6.92e-06	5.11e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.83e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SREBF1—metabolic syndrome X	6.81e-06	5.03e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CETP—metabolic syndrome X	6.79e-06	5.01e-05	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—metabolic syndrome X	6.74e-06	4.98e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMGCR—metabolic syndrome X	6.63e-06	4.89e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GOT2—metabolic syndrome X	6.63e-06	4.89e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOB—metabolic syndrome X	6.52e-06	4.81e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOB—metabolic syndrome X	6.52e-06	4.81e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SCARB1—metabolic syndrome X	6.5e-06	4.8e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	6.5e-06	4.8e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARA—metabolic syndrome X	6.47e-06	4.77e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCA1—metabolic syndrome X	6.45e-06	4.76e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC2A4—metabolic syndrome X	6.45e-06	4.76e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PLA2G4A—metabolic syndrome X	6.34e-06	4.68e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PLA2G4A—metabolic syndrome X	6.34e-06	4.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	6.32e-06	4.66e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SREBF1—metabolic syndrome X	6.31e-06	4.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AGT—metabolic syndrome X	6.26e-06	4.62e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GOT1—metabolic syndrome X	6.24e-06	4.61e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GGT1—metabolic syndrome X	6.24e-06	4.61e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—LPL—metabolic syndrome X	6.23e-06	4.59e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—LPL—metabolic syndrome X	6.23e-06	4.59e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—metabolic syndrome X	6.14e-06	4.53e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMGCR—metabolic syndrome X	6.14e-06	4.53e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GOT2—metabolic syndrome X	6.14e-06	4.53e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOA1—metabolic syndrome X	6.07e-06	4.48e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	6.02e-06	4.44e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.98e-06	4.41e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FABP4—metabolic syndrome X	5.94e-06	4.38e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CD36—metabolic syndrome X	5.92e-06	4.37e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CD36—metabolic syndrome X	5.92e-06	4.37e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCA1—metabolic syndrome X	5.91e-06	4.36e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC2A4—metabolic syndrome X	5.91e-06	4.36e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GOT1—metabolic syndrome X	5.72e-06	4.22e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GGT1—metabolic syndrome X	5.72e-06	4.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	5.63e-06	4.16e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARA—metabolic syndrome X	5.5e-06	4.06e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARA—metabolic syndrome X	5.5e-06	4.06e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCA1—metabolic syndrome X	5.47e-06	4.04e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC2A4—metabolic syndrome X	5.47e-06	4.04e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARG—metabolic syndrome X	5.35e-06	3.95e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGT—metabolic syndrome X	5.33e-06	3.93e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGT—metabolic syndrome X	5.33e-06	3.93e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOB—metabolic syndrome X	5.3e-06	3.91e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GGT1—metabolic syndrome X	5.3e-06	3.91e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GOT1—metabolic syndrome X	5.3e-06	3.91e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—INS—metabolic syndrome X	5.24e-06	3.87e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—metabolic syndrome X	5.22e-06	3.85e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—metabolic syndrome X	5.22e-06	3.85e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	5.19e-06	3.83e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	5.18e-06	3.82e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOA1—metabolic syndrome X	5.16e-06	3.81e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOA1—metabolic syndrome X	5.16e-06	3.81e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLA2G4A—metabolic syndrome X	5.15e-06	3.8e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FMO3—metabolic syndrome X	5.14e-06	3.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LPL—metabolic syndrome X	5.06e-06	3.73e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—G6PD—metabolic syndrome X	5.02e-06	3.7e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HDAC3—metabolic syndrome X	4.9e-06	3.61e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOB—metabolic syndrome X	4.86e-06	3.58e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	4.84e-06	3.57e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—metabolic syndrome X	4.81e-06	3.55e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CD36—metabolic syndrome X	4.81e-06	3.55e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPA—metabolic syndrome X	4.79e-06	3.53e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCKR—metabolic syndrome X	4.79e-06	3.53e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLA2G4A—metabolic syndrome X	4.72e-06	3.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	4.64e-06	3.42e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LPL—metabolic syndrome X	4.64e-06	3.42e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—metabolic syndrome X	4.6e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA5—metabolic syndrome X	4.59e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	4.58e-06	3.38e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	4.58e-06	3.38e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARG—metabolic syndrome X	4.55e-06	3.35e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARG—metabolic syndrome X	4.55e-06	3.35e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOB—metabolic syndrome X	4.5e-06	3.32e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARA—metabolic syndrome X	4.47e-06	3.3e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—INS—metabolic syndrome X	4.46e-06	3.29e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—INS—metabolic syndrome X	4.46e-06	3.29e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CD36—metabolic syndrome X	4.41e-06	3.25e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	4.38e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLA2G4A—metabolic syndrome X	4.37e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGT—metabolic syndrome X	4.33e-06	3.19e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	4.3e-06	3.18e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LPL—metabolic syndrome X	4.29e-06	3.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TRIB3—metabolic syndrome X	4.27e-06	3.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—metabolic syndrome X	4.24e-06	3.13e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—metabolic syndrome X	4.21e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOA1—metabolic syndrome X	4.19e-06	3.09e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	4.11e-06	3.03e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARA—metabolic syndrome X	4.1e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—metabolic syndrome X	4.09e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—metabolic syndrome X	4.09e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CD36—metabolic syndrome X	4.08e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGT—metabolic syndrome X	3.97e-06	2.93e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—metabolic syndrome X	3.95e-06	2.91e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—metabolic syndrome X	3.91e-06	2.89e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—metabolic syndrome X	3.91e-06	2.89e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—metabolic syndrome X	3.89e-06	2.87e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOA1—metabolic syndrome X	3.84e-06	2.84e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAMPT—metabolic syndrome X	3.83e-06	2.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LIPC—metabolic syndrome X	3.8e-06	2.81e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCK—metabolic syndrome X	3.8e-06	2.81e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARA—metabolic syndrome X	3.79e-06	2.8e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOC3—metabolic syndrome X	3.78e-06	2.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARG—metabolic syndrome X	3.69e-06	2.73e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGT—metabolic syndrome X	3.67e-06	2.71e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CETP—metabolic syndrome X	3.67e-06	2.71e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FABP4—metabolic syndrome X	3.66e-06	2.7e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—INS—metabolic syndrome X	3.62e-06	2.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.6e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—metabolic syndrome X	3.6e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—metabolic syndrome X	3.58e-06	2.64e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—metabolic syndrome X	3.58e-06	2.64e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOA1—metabolic syndrome X	3.56e-06	2.63e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SCARB1—metabolic syndrome X	3.51e-06	2.59e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	3.47e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SREBF1—metabolic syndrome X	3.41e-06	2.52e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARG—metabolic syndrome X	3.39e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—metabolic syndrome X	3.32e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—INS—metabolic syndrome X	3.32e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GOT2—metabolic syndrome X	3.32e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMGCR—metabolic syndrome X	3.32e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.25e-06	2.4e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—metabolic syndrome X	3.18e-06	2.34e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARG—metabolic syndrome X	3.13e-06	2.31e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—G6PD—metabolic syndrome X	3.09e-06	2.28e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—INS—metabolic syndrome X	3.07e-06	2.27e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—metabolic syndrome X	3.04e-06	2.25e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	3.02e-06	2.23e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCA1—metabolic syndrome X	2.96e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	2.96e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPA—metabolic syndrome X	2.95e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCKR—metabolic syndrome X	2.95e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—metabolic syndrome X	2.91e-06	2.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—metabolic syndrome X	2.91e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GGT1—metabolic syndrome X	2.86e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GOT1—metabolic syndrome X	2.86e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	2.86e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA5—metabolic syndrome X	2.83e-06	2.09e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—metabolic syndrome X	2.82e-06	2.08e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—metabolic syndrome X	2.7e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—metabolic syndrome X	2.66e-06	1.97e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.63e-06	1.94e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—metabolic syndrome X	2.47e-06	1.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOB—metabolic syndrome X	2.43e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	2.36e-06	1.75e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.36e-06	1.74e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.34e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.34e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.33e-06	1.72e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPL—metabolic syndrome X	2.32e-06	1.71e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.26e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CD36—metabolic syndrome X	2.21e-06	1.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.17e-06	1.6e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—metabolic syndrome X	2.11e-06	1.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	2.1e-06	1.55e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARA—metabolic syndrome X	2.05e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	2.04e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GOT2—metabolic syndrome X	2.04e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGT—metabolic syndrome X	1.99e-06	1.47e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—metabolic syndrome X	1.95e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.92e-06	1.42e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.82e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.82e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—metabolic syndrome X	1.8e-06	1.33e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—metabolic syndrome X	1.8e-06	1.33e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.76e-06	1.3e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.76e-06	1.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.69e-06	1.25e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—INS—metabolic syndrome X	1.66e-06	1.23e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—metabolic syndrome X	1.52e-06	1.12e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.5e-06	1.11e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—metabolic syndrome X	1.46e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.46e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.46e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.43e-06	1.06e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.36e-06	1e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—metabolic syndrome X	1.34e-06	9.88e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.33e-06	9.84e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.26e-06	9.32e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—metabolic syndrome X	1.24e-06	9.15e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.22e-06	9.03e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.2e-06	8.85e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.18e-06	8.74e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.04e-06	7.7e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—INS—metabolic syndrome X	1.02e-06	7.56e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—metabolic syndrome X	9.39e-07	6.93e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—metabolic syndrome X	8.98e-07	6.63e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	8.21e-07	6.06e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—metabolic syndrome X	6.7e-07	4.94e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—metabolic syndrome X	4.13e-07	3.05e-06	CbGpPWpGaD
